Oorsprong van het eerstegraads netwerk van Wolfgang Barth
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Avontec GmbH
 Avontec GmbH Pharmaceuticals: MajorHealth Technology Avontec is a Phase 2 biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for inflammatory disease. Its clinical development programs include product candidates for multiple potential inflammatory indications. The two most advanced, AVT-01 in asthma and AVT-02 in psoriasis, have successfully advanced into Phase 2a clinical trials that the firm expects to be completed until the first half of 2008. In addition, there are several candidates in the pipeline based on Avontec's core decoy technology. Avontec operates based on a lean business model with a seasoned management team experienced in clinical development.
2
| Extinct | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wolfgang Barth via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Masters Business Admin | |
| Portus Corporate Finance | Corporate Officer/Principal |
Statistieken
Internationaal
| Duitsland | 6 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Director of Finance/CFO | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
| Corporate Officer/Principal | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Thomas Fink | 4 |
| Stefan W. Henning | 3 |
- Beurs
- Insiders
- Wolfgang Barth
- Bedrijfsconnecties
